Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Current Eye Research
|
November 1, 1987
Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action
C E Crosson, J A Burke, M F Chan, et al.
The Journal of Pediatrics
|
February 1, 1977
Treatment of high-renin hypertension with propranolol in children after renal transplantation
D E Potter, M Schambelan, O Salvatierra, et al.
Pharmacology
|
January 1, 1978
Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons
L C Woodson, R R Kempen, D E Bee, et al.
Journal of Ocular Pharmacology
|
January 1, 1990
Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential
D E Potter, C E Crosson, A R Heath, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 22, 1998
Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine
T C Chu, R R Socci, M J Ogidigben, et al.
ANZ Journal of Surgery
|
March 1, 2016
Perineal tap water burns in the elderly: at what cost?
Michael D E Potter, Peter K M Maitz, Peter J Kennedy, et al.
Current Eye Research
|
September 1, 1996
Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors
T C Chu, W Wong, C Gluchowski, et al.
Kidney International
|
October 11, 1991
Long-term results of renal transplantation in children
D E Potter, J Najarian, F Belzer, et al.
The Journal of Allergy and Clinical Immunology
|
September 1, 1977
Metabolic and cardiovascular effects of carbuterol and metaproterenol
J P Sanders, D E Potter, S Ellis, et al.
Journal of Ocular Pharmacology
|
January 1, 1987
Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonist
D F Woodward, G D Novack, L S Williams, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Current Eye Research
|
November 1, 1987
Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action
C E Crosson, J A Burke, M F Chan, et al.
The Journal of Pediatrics
|
February 1, 1977
Treatment of high-renin hypertension with propranolol in children after renal transplantation
D E Potter, M Schambelan, O Salvatierra, et al.
Pharmacology
|
January 1, 1978
Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons
L C Woodson, R R Kempen, D E Bee, et al.
Journal of Ocular Pharmacology
|
January 1, 1990
Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential
D E Potter, C E Crosson, A R Heath, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 22, 1998
Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine
T C Chu, R R Socci, M J Ogidigben, et al.
ANZ Journal of Surgery
|
March 1, 2016
Perineal tap water burns in the elderly: at what cost?
Michael D E Potter, Peter K M Maitz, Peter J Kennedy, et al.
Current Eye Research
|
September 1, 1996
Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors
T C Chu, W Wong, C Gluchowski, et al.
Kidney International
|
October 11, 1991
Long-term results of renal transplantation in children
D E Potter, J Najarian, F Belzer, et al.
The Journal of Allergy and Clinical Immunology
|
September 1, 1977
Metabolic and cardiovascular effects of carbuterol and metaproterenol
J P Sanders, D E Potter, S Ellis, et al.
Journal of Ocular Pharmacology
|
January 1, 1987
Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonist
D F Woodward, G D Novack, L S Williams, et al.
Page
of 10